ethosuximide

North America

Canada (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ZARONTIN CAP 250MG caps
Rx
oral
N03AD01
ZARONTIN SYR 250MG/5ML syrup
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ZARONTIN CAP 250MG caps
00022799
ZARONTIN SYR 250MG/5ML syrup
00023485
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMIDE 250MG caps
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG caps
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG caps
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG caps
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG caps
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG/5ML syrup
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG/5ML syrup
Y
Rx
oral
N03AD01
ETHOSUXIMIDE 250MG/5ML syrup
N
oral
N03AD01
ZARONTIN 250MG caps
Y
Rx
oral
N03AD01
ZARONTIN 250MG/5ML syrup
Y
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMIDE 250MG caps
40686/1
ANDA
28-05-2008
ETHOSUXIMIDE 250MG caps
40430/1
ANDA
28-10-2002
ETHOSUXIMIDE 250MG caps
200892/1
ANDA
25-09-2012
ETHOSUXIMIDE 250MG caps
210654/1
ANDA
16-03-2020
ETHOSUXIMIDE 250MG caps
211928/1
ANDA
19-02-2019
ETHOSUXIMIDE 250MG/5ML syrup
40506/1
ANDA
22-12-2003
ETHOSUXIMIDE 250MG/5ML syrup
40253/1
ANDA
22-11-2000
ETHOSUXIMIDE 250MG/5ML syrup
81306/1
ANDA
30-07-1993
ZARONTIN 250MG caps
12380/1
NDA
01-01-1982
ZARONTIN 250MG/5ML syrup
80258/1
ANDA
01-01-1982
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMID NEURAXPHARM 250 MG WEICH -
Rx
-
N03AD01
ETHOSUXIMID NEURAXPHARM 50 MG/ML oral sol
Rx
-
N03AD01
PETINIMID caps
Rx
-
N03AD01
PETINIMID syrup
Rx
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMID NEURAXPHARM 250 MG WEICH -
139319
23-12-2019
ETHOSUXIMID NEURAXPHARM 50 MG/ML oral sol
139260
06-12-2019
PETINIMID caps
12017
21-08-1962
PETINIMID syrup
11686
13-03-1967
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ZARONTIN 250 MG/5 ML syrup
200 mL
240 mL
Y
-

oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ZARONTIN 250 MG/5 ML syrup
200 mL
240 mL
BE004584
BE004584
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ZARONTIN 250 MG/5 ML syrup
200 mL
240 mL
1,72
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PETINIMID 250MG caps, soft
250MG 100
250MG 50
Y
N
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PETINIMID 250MG caps, soft
250MG 100
250MG 50
21/ 634/70-C
21/ 634/70-C
NP
NP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
PETINIMID 250MG caps, soft
250MG 100
250MG 50
214,24
0
320,03
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMID 2CARE4 50 MG/ML oral sol
-
-
N03AD01
ETHOSUXIMID PARANOVA 50 MG/ML oral sol
-
-
N03AD01
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
-
-
N03AD01
ZARONDAN 50 MG/ML oral sol
-
-
N03AD01
ZARONDAN 50 MG/ML oral sol
-
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMID 2CARE4 50 MG/ML oral sol
28106082018
PI
14-05-2018
ETHOSUXIMID PARANOVA 50 MG/ML oral sol
28106252619
PI
04-09-2019
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
28106147218
DCP
12-09-2019
ZARONDAN 50 MG/ML oral sol
28100400362
NP
29-06-1962
ZARONDAN 50 MG/ML oral sol
28106152118
PI
15-10-2018
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ETHOSUXIMID 2CARE4 50 MG/ML oral sol
ETHOSUXIMID PARANOVA 50 MG/ML oral sol
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
ZARONDAN 50 MG/ML oral sol
ZARONDAN 50 MG/ML oral sol
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ZARONTIN 250 MG/5 ML 250/5 MG/ML syrup
-
Rx
oral
N03AD01
ZARONTIN 250MG/5ML 250MG/ML MICROMOLE syrup
Y
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ZARONTIN 250 MG/5 ML 250/5 MG/ML syrup
PPA0465/456/001
18-09-2020
ZARONTIN 250MG/5ML 250MG/ML MICROMOLE syrup
PA22644/005/001
04-11-2016
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PETINIMID 250 MG caps, hard
N100 nenurodyta
oral
N03AD01
PETINIMID 50 MG/ML syrup
250 ml N1 bottle
Rx
oral
N03AD01
PETNIDAN 250 MG caps, hard
N100 nenurodyta
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PETINIMID 250 MG caps, hard
N100 nenurodyta
Nominal
PETINIMID 50 MG/ML syrup
250 ml N1 bottle
Nominal
PETNIDAN 250 MG caps, hard
N100 nenurodyta
Nominal
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EMESIDE 250MG/5ML / ETHOSUXIMIDE ESSENTIAL GENERICS 250MG/5 syrup
Rx
-
N03AD01
EMUSIDE ETHOSUXIMIDE ESSENTIAL GENERICS 250MG caps
Rx
-
N03AD01
ETHOSUXIMIDE 250MG caps, soft
Rx
-
N03AD01
ETHOSUXIMIDE 250MG , SOFT caps, soft
Rx
-
N03AD01
ETHYMAL , SOFT 250MG caps, soft
Rx
-
N03AD01
ZARONTIN 250MG/5ML syrup
Rx
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EMESIDE 250MG/5ML / ETHOSUXIMIDE ESSENTIAL GENERICS 250MG/5 syrup
AA565/30801
11-09-2017
EMUSIDE ETHOSUXIMIDE ESSENTIAL GENERICS 250MG caps
AA565/38001
25-09-2018
ETHOSUXIMIDE 250MG caps, soft
AA244/10001
15-09-2008
ETHOSUXIMIDE 250MG , SOFT caps, soft
AA565/65701
06-05-2020
ETHYMAL , SOFT 250MG caps, soft
AA565/32901
17-01-2018
ZARONTIN 250MG/5ML syrup
AA729/21101
29-05-2018
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMIDE STRIDES 250 MG caps, soft
-
Rx
oral
N03AD01
ETHYMAL 125 MG, caps, soft
-
Rx
oral
N03AD01
ETHYMAL 250 MG, caps, soft
-
Rx
oral
N03AD01
ETHYMAL 250 MG/4 ML syrup
-
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMIDE STRIDES 250 MG caps, soft
RVG 123574
-
21-08-2019
ETHYMAL 125 MG, caps, soft
RVG 05634
-
11-09-1968
ETHYMAL 250 MG, caps, soft
RVG 02982
-
15-12-1967
ETHYMAL 250 MG/4 ML syrup
RVG 02984
-
15-12-1967
Product
Pack
SPC
PIL
Company
ETHOSUXIMIDE STRIDES 250 MG caps, soft
ETHYMAL 125 MG, caps, soft
ETHYMAL 250 MG, caps, soft
ETHYMAL 250 MG/4 ML syrup
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
100
-
Rx
oral
N03AD01
PETNIDAN 250 MG caps
100
-
Rx
oral
N03AD01
PETNIDAN 50 MG/ML Mikstur
250
-
Rx
oral
N03AD01
SUXINUTIN 50 MG/ML Mikstur
200
-
Rx
-
N03AD01
ZARONTIN 250 MG caps
100
-
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
100
15-06-2020
PETNIDAN 250 MG caps
100
01-08-2005
PETNIDAN 50 MG/ML Mikstur
250
15-06-2017
SUXINUTIN 50 MG/ML Mikstur
200
01-01-2001
ZARONTIN 250 MG caps
100
15-07-2007
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PETINIMID 250 MG caps
100 caps
-
Rx
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PETINIMID 250 MG caps
100 caps
02449
NP
Product
Pack
SPC
PIL
Company
PETINIMID 250 MG caps
100 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PETINIMID 250 MG CAPS. MOI
10 blister din PVC-PVDC/Al x 10 caps moi
-
P6L
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PETINIMID 250 MG CAPS. MOI
10 blister din PVC-PVDC/Al x 10 caps moi
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ASAMID (250 MG/5 ML) syrup
steklenička 200 ml syrupa
-
Rx
oral
N03AD01
PETNIDAN 250 MG caps, hard
plastenko 50 caps
N
-
N03AD01
PETNIDAN 250 MG/5 ML syrup
stekleničko 250 ml syrupa
N
-
N03AD01
SUXINUTIN 250 MG (NI VEč NA TRžIščU) caps
100 caps
50 caps
-
-
Rx
Rx
oral
N03AD01
ZARONTIN 250 MG caps
50 caps
-
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ASAMID (250 MG/5 ML) syrup
steklenička 200 ml syrupa
-
PETNIDAN 250 MG caps, hard
plastenko 50 caps
842-108/2021
-
30-03-2021
30-03-2022
PETNIDAN 250 MG/5 ML syrup
stekleničko 250 ml syrupa
842-86/2021
-
19-03-2021
19-03-2022
SUXINUTIN 250 MG (NI VEč NA TRžIščU) caps
100 caps
50 caps
-
-
ZARONTIN 250 MG caps
50 caps
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ASAMID (250 MG/5 ML) syrup
steklenička 200 ml syrupa
PETNIDAN 250 MG caps, hard
plastenko 50 caps
24,17
PETNIDAN 250 MG/5 ML syrup
stekleničko 250 ml syrupa
27,11
SUXINUTIN 250 MG (NI VEč NA TRžIščU) caps
100 caps
50 caps
ZARONTIN 250 MG caps
50 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETOSUXIMIDA FAES 250 MG caps, hard
30 caps
Y
Rx
oral
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETOSUXIMIDA FAES 250 MG caps, hard
30 caps
42250
01-01-1966
Product
Pack
SPC
PIL
Company
ETOSUXIMIDA FAES 250 MG caps, hard
30 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (11)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
Rx
-
N03AD01
ETOSUXIMID 2CARE4 50 MG/ML oral sol
Rx
Rx
-
N03AD01
ETOSUXIMID ABBOXIA 50 MG/ML oral sol
Rx
-
N03AD01
ETOSUXIMID EBB (FD SUXINUTIN) 50 MG/ML oral sol
Rx
-
N03AD01
ETOSUXIMID EBB 50 MG/ML oral sol
Rx
-
N03AD01
ETOSUXIMID MEDARTUUM (FD SUXINUTIN) 50 MG/ML oral sol
Rx
-
N03AD01
ETOSUXIMID PARANOVA 50 MG/ML oral sol
Rx
-
N03AD01
SUXINUTIN (FD ETOSUXIMID ORIFARM) 50 MG/ML oral sol
Rx
-
N03AD01
SUXINUTIN 250 MG caps, soft
Rx
-
N03AD01
SUXINUTIN 50 MG/ML oral sol
Rx
-
N03AD01
SUXINUTIN 50 MG/ML oral sol
Rx
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETHOSUXIMIDE ORIFARM 250 MG caps, soft
Nationell decentral eller ömsesidig
24-09-2019
ETOSUXIMID 2CARE4 50 MG/ML oral sol
PI
PI
17-10-2018
11-07-2019
ETOSUXIMID ABBOXIA 50 MG/ML oral sol
PI
25-09-2019
ETOSUXIMID EBB (FD SUXINUTIN) 50 MG/ML oral sol
PI
04-10-2018
31-12-2020
ETOSUXIMID EBB 50 MG/ML oral sol
PI
03-03-2021
ETOSUXIMID MEDARTUUM (FD SUXINUTIN) 50 MG/ML oral sol
PI
11-07-2019
ETOSUXIMID PARANOVA 50 MG/ML oral sol
PI
24-03-2020
SUXINUTIN (FD ETOSUXIMID ORIFARM) 50 MG/ML oral sol
PI
18-09-2019
SUXINUTIN 250 MG caps, soft
Nationell decentral eller ömsesidig
18-10-1963
31-12-2004
SUXINUTIN 50 MG/ML oral sol
Nationell decentral eller ömsesidig
18-10-1963
SUXINUTIN 50 MG/ML oral sol
PI
25-02-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
PETINIMID caps
-
B
-
N03AD01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
PETINIMID caps
29934 1
Hauptzulassung
23-07-1963
09-07-2024
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.